Nath Bio-Genes Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 2,895.87 million compared to INR 2,563.76 million a year ago. Revenue was INR 2,895.87 million compared to INR 2,563.76 million a year ago. Net income was INR 385 million compared to INR 335.75 million a year ago. Basic earnings per share from continuing operations was INR 20.29 compared to INR 17.67 a year ago. Diluted earnings per share from continuing operations was INR 20.29 compared to INR 17.67 a year ago.